Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Attendees who have favorited this...

  • Matthew Allan
    Senior Manager, Regulatory Intelligence
    Regeneron Pharmaceuticals Inc - ENTERPRISE
  • Susan Carino
    Principal Consultant
    Integrated Project Management Company (IPM)
  • Simon Cournoyer
    Associate Director, Regulatory Affairs
    Merck Canada Inc.
  • Michael Ferry
    Regulatory Affairs Specialist
    Medtronic, Inc - North Haven, CT
  • Tracey Fox
    Executive Director, Regulatory Affairs
    Olympus Corporation
  • Kristi Frisch
    Regulatory Affairs Specialist, Principal
    Arthrex
  • Jens Hofmann
    Dipl.Ing.
    Siemens Healthcare GmbH
  • Vincent Hohn
    Global Regulatory Lead
    Takeda R&D - PDT
  • ValĂ©rie Joseph
    Director, Regulatory Affairs & Pharmacovigilance
    Organon Canada Inc.
  • Tara Miller
    Clinical and Regulatory Affairs and Human Factors
    Sterling Medical Devices
  • Alex Morris
    VIDA Diagnostics, Inc.
  • Leyna Mulholland
    Director, Global Regulatory Affairs
    Jazz Pharmaceuticals - ENTERPRISE
  • Diana Najarian
    Senior Manager, Nonclinical Writing
    Alnylam Pharmaceuticals
  • Jennifer Richardson
    Director, Regulatory Affairs
    Exactech
  • THERESA Shalaby
    Director, Regulatory Affairs
    Sarah Cannon Research Institute
  • Ajay Taluja
    Associate Director, Regulatory Affairs CMC
    Cytokinetics
  • Darlene Welsh
    Sr. Director, Regulatory Affairs
    Integra Lifesciences Corp